Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
about
Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington's disease.Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.Very-low-density lipoprotein: complex particles in cardiac energy metabolism.Ectopic lipid storage and insulin resistance: a harmful relationship.Mitochondrial dysfunction and its impact on diabetic heart.Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy
P2860
Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
@en
Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
@nl
type
label
Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
@en
Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
@nl
prefLabel
Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
@en
Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
@nl
P2860
P1476
Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.
@en
P2093
Rhys D Evans
You-Guo Niu
P2860
P304
P356
10.1113/JPHYSIOL.2009.173542
P407
P577
2009-05-11T00:00:00Z